These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling. Reid SM; Walstab JE; Chong D; Westbury C; Reddihough DS J Craniofac Surg; 2013 Jan; 24(1):28-33. PubMed ID: 23348253 [TBL] [Abstract][Full Text] [Related]
45. Primary treatment of early fistula of parotid duct with botulinum toxin type A injection. Ferron C; Cernea SS; Almeida ART; Cesar DVG An Bras Dermatol; 2017; 92(6):864-866. PubMed ID: 29364451 [TBL] [Abstract][Full Text] [Related]
46. Tolerance of salivary gland botulinum toxin A injection under local anesthesia for the treatment of sialorrhea in children: An observational study. Toulemonde P; Maltezeanu A; Broucqsault H; Fayoux P Eur Ann Otorhinolaryngol Head Neck Dis; 2022 Mar; 139(2):77-81. PubMed ID: 34217684 [TBL] [Abstract][Full Text] [Related]
47. Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A. Tiigimäe-Saar J; Tamme T; Rosenthal M; Kadastik-Eerme L; Taba P Neurol Sci; 2018 May; 39(5):871-877. PubMed ID: 29460161 [TBL] [Abstract][Full Text] [Related]
48. Treatment of Parotid Sialocele after Sustaining a Facial Injury. Case Report and Literature Review. Lee J; Nolan P; Baker J N Y State Dent J; 2016 Mar; 82(2):27-32. PubMed ID: 27209715 [TBL] [Abstract][Full Text] [Related]
49. [Blocking secretion of exocrine glands in the head-neck area by administration of botulinum toxin A. Therapy of a rare disease picture]. Ellies M; Laskawi R; Rohrbach-Volland S; Rödel R; Beuche W HNO; 2001 Oct; 49(10):807-13. PubMed ID: 11699140 [TBL] [Abstract][Full Text] [Related]
50. Management and Follow-up Results of Salivary Fistulas Treated With Botulinum Toxin. Send T; Bertlich M; Eichhorn KW; Bootz F; Jakob M Laryngoscope; 2019 Feb; 129(2):403-408. PubMed ID: 30151958 [TBL] [Abstract][Full Text] [Related]
51. Diagnosis and therapeutic management of iatrogenic parotid sialocele. Capaccio P; Paglia M; Minorati D; Manzo R; Ottaviani F Ann Otol Rhinol Laryngol; 2004 Jul; 113(7):562-4. PubMed ID: 15274417 [TBL] [Abstract][Full Text] [Related]
52. Iatrogenic transposition of the parotid duct into the maxillary sinus after tooth extraction and closure of an oroantral fistula. A case report. Neuschl M; Kluba S; Krimmel M; Reinert S J Craniomaxillofac Surg; 2010 Oct; 38(7):538-40. PubMed ID: 20494589 [TBL] [Abstract][Full Text] [Related]
53. Botulinum toxin B reduces sialorrhea in parkinsonism. Racette BA; Good L; Sagitto S; Perlmutter JS Mov Disord; 2003 Sep; 18(9):1059-61. PubMed ID: 14502678 [TBL] [Abstract][Full Text] [Related]
54. Botulinum Toxin A in the Management of Pediatric Sialorrhea: A Systematic Review. Heikel T; Patel S; Ziai K; Shah SJ; Lighthall JG Ann Otol Rhinol Laryngol; 2023 Feb; 132(2):200-206. PubMed ID: 35176902 [TBL] [Abstract][Full Text] [Related]
55. Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis. Manrique D Braz J Otorhinolaryngol; 2005; 71(5):566-9. PubMed ID: 16612515 [TBL] [Abstract][Full Text] [Related]
56. Surgical management of Stenson's duct injury using epidural catheter: a novel technique. Kumar SR; Hiremath V; Patil AG; Aparna S Niger J Clin Pract; 2013; 16(2):266-8. PubMed ID: 23563476 [TBL] [Abstract][Full Text] [Related]
58. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472 [TBL] [Abstract][Full Text] [Related]
59. Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Dogu O; Apaydin D; Sevim S; Talas DU; Aral M Clin Neurol Neurosurg; 2004 Mar; 106(2):93-6. PubMed ID: 15003297 [TBL] [Abstract][Full Text] [Related]
60. Efficacy and Non Invasive Treatment of Sialorrhea in the Goldenhar Syndrome. Marvulli R; Gallo GA; Mastromauro L; Dicuonzo F; Fiore P; Ianieri G; Megna M Endocr Metab Immune Disord Drug Targets; 2018; 18(4):397-400. PubMed ID: 29595115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]